Veeva Announces Share Repurchase Program
Veeva (NYSE: VEEV) announced on Jan. 5, 2026 that its board approved a share repurchase program authorizing up to $2.0 billion of Class A common stock purchases.
Rhea-AI Summary
Veeva (NYSE: VEEV) announced on Jan. 5, 2026 that its board approved a share repurchase program authorizing up to $2.0 billion of Class A common stock purchases.
The program may use open-market purchases, privately negotiated transactions, or Rule 10b5-1 trading plans and will comply with Rule 10b-18 and other applicable laws. The program term is 2 years, repurchases are at management discretion, and Veeva is not obligated to buy any specific number of shares; the program may be suspended or cancelled at any time.
Positive
- $2.0 billion repurchase authorization
- Program term: 2 years
- Permits open-market and negotiated purchases
Negative
- No obligation to purchase a specific number of shares
- Repurchases subject to management discretion and market conditions
- Program may be cancelled or suspended at any time
Details
News Market Reaction – VEEV
In the Jan 6 session, VEEV gained 7.48%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Buyback authorization
- $2 billion
- Maximum Class A share repurchases under new program
- Program term
- 2 years
- Duration of authorized share repurchase program
Historical Context
-
Upcoming presentation at Raymond James 2025 TMT and Consumer Conference.
-
Launch of Veeva AI Agents for Vault CRM and PromoMats.
-
Roche expanding use of Veeva Vault CRM and Veeva AI capabilities.
-
Strong fiscal 2026 Q3 growth in revenue, income, and AI and cloud progress.
-
More than 100 emerging biotechs adopting Veeva Basics across operations.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
rule 10b5-1 regulatory
rule 10b-18 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
"The breadth of our multi-product business, paired with a focus on operational discipline, innovation, and customer success, continues to drive financial outperformance and robust cash generation. This strength provides Veeva the healthy balance sheet to invest in the significant opportunities ahead and to return capital to shareholders," said chief financial officer Brian Van Wagener. "These ongoing investments in product excellence and the launch of our first ever share repurchase program reflect the confidence we have in our long-term growth trajectory and the enduring value we can deliver across the life sciences industry."
Under the program, Veeva may repurchase shares from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), in accordance with applicable securities laws and other restrictions, including Rule 10b-18 under the Exchange Act. The timing and total amount of any stock repurchases will be determined at management's discretion and depend upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The share repurchase program has a term of 2 years, does not obligate Veeva to acquire a specific number of shares of Class A common stock, and may be canceled or suspended at any time without notice.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit veeva.com.
Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's intended share repurchases. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.
Investor Relations Contact: | Media Contact: | |
Gunnar Hansen | Maria Scurry | |
Veeva Systems Inc. | Veeva Systems Inc. | |
267-460-5839 | 781-366-7617 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-announces-share-repurchase-program-302653096.html
SOURCE Veeva Systems